With no cure in sight, any new approval ushers in hope, including with an agent like Leqembi that slowed progression of the disease an average of 27% in research.
from WebMD Health https://ift.tt/zL9QvBg
With no cure in sight, any new approval ushers in hope, including with an agent like Leqembi that slowed progression of the disease an average of 27% in research.
It’s hot as Hades and the power’s out. Now what?
Rheumatoid arthritis can make it hard to stay active. Andy Pendergrass of Louisiana shares how he keeps his athletic dreams alive.
Humans have reached the peak of their ability to adjust to extreme heat conditions. What comes next is not pretty.